Scarica l'app Stockscreener
4.71
1.07%
0.05
Dopo l'orario di chiusura:
4.71
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SGHT Giù?
Forum
Previsione
Precedente Chiudi:
$4.66
Aprire:
$4.68
Volume 24 ore:
512.44K
Relative Volume:
2.90
Capitalizzazione di mercato:
$239.46M
Reddito:
$81.06M
Utile/perdita netta:
$-55.55M
Rapporto P/E:
-3.226
EPS:
-1.46
Flusso di cassa netto:
$-47.98M
1 W Prestazione:
-10.63%
1M Prestazione:
-18.93%
6M Prestazione:
-20.97%
1 anno Prestazione:
+158.79%
Intervallo 1D:
$4.56
$4.90
Intervallo di 1 settimana:
$4.46
$5.48
Portata 52W:
$1.575
$8.45
Sight Sciences Inc Stock (SGHT) Company Profile
Nome
Sight Sciences Inc
Settore
Industria
Telefono
(415) 889-0550
Indirizzo
4040 CAMPBELL AVE,, MENLO PARK
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-21 | Iniziato | Lake Street | Buy |
| 2023-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-06 | Aggiornamento | Stifel | Hold → Buy |
| 2022-10-04 | Iniziato | Needham | Hold |
| 2022-07-26 | Iniziato | Stifel | Hold |
| 2022-02-03 | Iniziato | William Blair | Outperform |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Sight Sciences Inc Borsa (SGHT) Ultime notizie
Lake Street cuts Sight Sciences stock rating to hold amid market challenges - Investing.com Australia
Lake Street Capital Markets Downgrades Sight Sciences Inc. (SGHT) to Hold - StreetInsider.com
Sight Sciences (NASDAQ:SGHT) Downgraded to Hold Rating by Lake Street Capital - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts - Defense World
Global Dry Eye Disease Treatment Market Projected to Cross USD 9 Billion by 2030 | DelveInsight - The Malaysian Reserve
Sight Sciences (SGHT) Scheduled to Post Earnings on Thursday - MarketBeat
Microsoft Co. (NASDAQ:MSFT) Shares Acquired by Parametrica Management Ltd - Defense World
KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares - Yahoo Finance
KCK LTD. Adjusts Stake in NeuroPace Inc - GuruFocus.com
Preview: Zynex's Earnings - Benzinga
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $122,471.91 in Stock - MarketBeat
Sight Sciences CCO Matthew Link sells $244,900 in stock By Investing.com - Investing.com South Africa
Sight Sciences CCO Matthew Link sells $244,900 in stock - Investing.com
The Manufacturers Life Insurance Company Increases Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World
The Manufacturers Life Insurance Company Buys New Position in Applied Optoelectronics, Inc. (NASDAQ:AAOI) - Defense World
The Manufacturers Life Insurance Company Invests $90,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
The Manufacturers Life Insurance Company Purchases Shares of 13,551 LifeMD, Inc. (NASDAQ:LFMD) - Defense World
The Manufacturers Life Insurance Company Invests $123,000 in Lincoln Educational Services Co. (NASDAQ:LINC) - Defense World
The Manufacturers Life Insurance Company Invests $102,000 in Backblaze, Inc. (NASDAQ:BLZE) - Defense World
Sight Sciences' IPO Lock-up Period Ends On Jan 11 - RTTNews
This Insider Has Just Sold Shares In Sight Sciences - Simply Wall St
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Matthew Link Sells 20,734 Shares - MarketBeat
Sight sciences' chief commercial officer sells shares worth $244,878 - Investing.com
Sight sciences' chief commercial officer sells shares worth $244,878 By Investing.com - Investing.com UK
KCK LTD. Reduces Stake in NeuroPace Inc - GuruFocus.com
Sight Sciences to Report Third Quarter Financial Results on November 7, 2024 - The Manila Times
GenSight Biologics Announces LUMEVOQ® Scientific Updates at AAO 2024 - Yahoo Finance
Dry Eye Disease Treatment Devices Market Size and Growth Analysis - News in Assen
(SGHT) Trading Report - Stock Traders Daily
Single TearCare® Treatment Improved Functional Visual - GlobeNewswire
Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial - StockTitan
Renaissance Technologies LLC Sells 105,556 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) - MarketBeat
Lineage Looking to Restore Sight, Hearing, Movement - San Diego Business Journal
Powered Surgical Instruments Market Growth Report, Analysis And Overview To 2033 - WhaTech
Have Sight Sciences Insiders Been Selling Stock? - Simply Wall St
(SGHT) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Sight Sciences shares reiterate Buy rating from Lake Street on growth potential - Investing.com
Sight Sciences CTO sells shares worth over $18k By Investing.com - Investing.com South Africa
Sight Sciences COO sells shares worth over $20,000 - Investing.com India
Sight Sciences COO sells shares worth over $20,000 By Investing.com - Investing.com South Africa
Reviewing WK Kellogg (NYSE:KLG) & Forafric Global (NASDAQ:AFRI) - Defense World
Aurubis (ETR:NDA) Stock Price Down 1% – Here’s Why - Defense World
Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 3,167 Shares of Stock - MarketBeat
Sight Sciences CEO Paul Badawi sells shares worth over $76k By Investing.com - Investing.com South Africa
Sight Sciences executive sells shares worth over $29,000 - Investing.com India
Sight Sciences executive sells shares worth over $29,000 By Investing.com - Investing.com Australia
Sight Sciences CEO Paul Badawi sells shares worth over $76k - Investing.com Australia
Sight Sciences CTO sells shares worth over $18k - Investing.com
Sight Sciences Inc Azioni (SGHT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):